National Academies Press: OpenBook
« Previous: 6 Overall Conclusions
Suggested Citation:"Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2024. Long-Term Health Effects of COVID-19: Disability and Function Following SARS-CoV-2 Infection. Washington, DC: The National Academies Press. doi: 10.17226/27756.
×
Page 225
Suggested Citation:"Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2024. Long-Term Health Effects of COVID-19: Disability and Function Following SARS-CoV-2 Infection. Washington, DC: The National Academies Press. doi: 10.17226/27756.
×
Page 226
Suggested Citation:"Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2024. Long-Term Health Effects of COVID-19: Disability and Function Following SARS-CoV-2 Infection. Washington, DC: The National Academies Press. doi: 10.17226/27756.
×
Page 227
Suggested Citation:"Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2024. Long-Term Health Effects of COVID-19: Disability and Function Following SARS-CoV-2 Infection. Washington, DC: The National Academies Press. doi: 10.17226/27756.
×
Page 228

Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Appendix A Public Meeting Agendas COMMITTEE ON THE LONG-TERM HEALTH EFFECTS STEMMING FROM COVID-19 AND IMPLICATIONS FOR THE SOCIAL SECURITY ADMINSTRATION The Keck Center, 500 Fifth Street, NW Washington, DC 20001 MEETING 1 JANUARY 26, 2023 VIRTUAL 3:05 p.m. Welcome and Introductions Paul Volberding, Committee Chair Steve Rollins, Acting Associate Commissioner, U.S. Social Security Administration (SSA) 3:15 p.m. Social Security Administration Overview Vincent Nibali, Policy Analyst, Office of Medical Policy & Office of Disability Policy •  Provide an overview of SSA and its mission/goals/processes • Explanation of interest in Long COVID and how it applies to their work • Explanation of the Statement of Task and key elements of interest to SSA 225 PREPUBLICATION COPY—Uncorrected Proofs A02506-Long-Term_Health_Effects_of_COVID-19_AppA.indd 225 5/21/24 11:30 AM

226 LONG-TERM HEALTH EFFECTS OF COVID-19 3:40 p.m. Questions and Discussion Committee Members and SSA Staff 4:30 p.m. Adjourn Public Session The Keck Center, 500 Fifth Street, NW Washington, DC 20001 MEETING 2 FEBRUARY 12, 2023 KECK 100 1:00 p.m. Welcome Paul Volberding, Committee Chair 1:05 p.m. Long COVID: Overview of the course of disease and demographics David Putrino, Director of Rehabilitation Innovation, Icahn School of Medicine at Mount Sinai 2:00 p.m. Current practices in defining and diagnosing Long COVID Director, Translational Neuroscience Center at National Institute of Neurological Disorders and Stroke 3:00 p.m. Adjourn Public Session University of California, San Francisco Medical Center at Mission Bay 550 16th Street, San Francisco, CA MEETING 3 MAY 9, 2023 MISSION HALL, ROOM 2105 12:00 p.m. Welcome and Opening Remarks Paul Volberding, Committee Chair 12:05 p.m. Immunology of Long COVID Akiko Iwasaki, Sterling Professor of Immunobiology and Professor of Dermatology and of Molecular, Cellular, and Developmental Biology and of Epidemiology (Microbial Diseases) at Yale School of Medicine; Investigator, Howard Hughes Medical Institute PREPUBLICATION COPY—Uncorrected Proofs A02506-Long-Term_Health_Effects_of_COVID-19_AppA.indd 226 5/21/24 11:30 AM

APPENDIX A 227 12:45 p.m. Long COVID and ME/CFS share both symptoms and underlying biological abnormalities Anthony Komaroff, Steven P. Simcox/Patrick A. Clifford/ James H. Higby Professor of Medicine at Harvard Medical School, Senior physician at Brigham and Women’s Hospital in Boston 1:30 p.m. BREAK 1:45 p.m. Epigenetic Diagnosis and the Human “Flight Data Recorder” Eric Van Gieson, Senior Advisor at The Conafay Group, Chief Executive Officer at Severn Innovations 2:30 p.m. Closing Remarks Paul Volberding, Committee Chair 2:35 p.m. Adjourn Public Session The National Academy of Sciences 2101 Constitution Ave NW Washington, DC 20418 MEETING 4 JULY 24, 2023 NAS BOARD ROOM 9:30 a.m. Welcome and Opening Remarks Paul Volberding, Committee Chair 9:35 a.m. Patient experience and follow-up Lucas Denault, Long COVID Patient Karin Denault, Parent and Caregiver 10:00 a.m. Long COVID in children and adolescents Alexandra Yonts, Director, Post COVID Program and Infectious Diseases Specialist, Children’s National Hospital 10:45 a.m. Underserved populations and Long COVID Angela Meriquez Vázquez, MSW, Long COVID Patient and Policy Director, The Children’s Partnership 11:30 a.m. Presentation to NASEM Committee on the Long-Term Health Effects Stemming from COVID-19 and Implications for the Social Security Administration Robert Holman, Medical Director, District of Columbia Fire and Emergency Medical Services Department 12:15 p.m. Closing Remarks Paul Volberding, Committee Chair 12:20 p.m. Adjourn Public Session PREPUBLICATION COPY—Uncorrected Proofs A02506-Long-Term_Health_Effects_of_COVID-19_AppA.indd 227 5/21/24 11:30 AM

PREPUBLICATION COPY—Uncorrected Proofs A02506-Long-Term_Health_Effects_of_COVID-19_AppA.indd 228 5/21/24 11:30 AM

Next: Appendix B: Literature Search Strategies »
Long-Term Health Effects of COVID-19: Disability and Function Following SARS-CoV-2 Infection Get This Book
×
 Long-Term Health Effects of COVID-19: Disability and Function Following SARS-CoV-2 Infection
Buy Prepub | $61.00 Buy Paperback | $52.00
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Since the onset of the coronavirus disease 2019 (COVID-19) pandemic in early 2020, many individuals infected with the virus that causes COVID-19, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have continued to experience lingering symptoms for months or even years following infection. Some symptoms can affect a person's ability to work or attend school for an extended period of time. Consequently, in 2022, the Social Security Administration requested that the National Academies convene a committee of relevant experts to investigate and provide an overview of the current status of diagnosis, treatment, and prognosis of long-term health effects related to Long COVID. This report presents the committee conclusions.

READ FREE ONLINE

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  6. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  7. ×

    View our suggested citation for this chapter.

    « Back Next »
  8. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!